全球去心房顫動市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，去心房顫動市場規模將達到 347.1 億美元，高於 2025 年的 189.9 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 6.93%。

由於心血管疾病和心臟麻痹病例的不斷增加，全球去心房顫動市場正經歷強勁成長。去心房顫動是一種救命設備，它透過電擊來恢復正常心率。人們對緊急醫療照護意識的提高以及公共場所自動體外心臟去心房顫動（AED）的普及是推動市場擴張的主要因素。此外，醫療技術的進步也提高了除顫器的效率和易用性。

成長要素包括醫院、救護車和公共場所對攜帶式、易用型去心房顫動（AED）的措施也促進了市場成長。此外，人們日益重視提升緊急應變能力，並擴大了心肺復甦術（CPR）和去心房顫動使用方面的培訓項目，這些都進一步刺激了市場需求。同時，技術進步也提高了設備的可靠性和性能。

展望未來，去心房顫動市場預計將因持續創新和心血管健康意識的不斷提高而顯著成長。具備即時監測功能的智慧互聯去心房顫動的研發將進一步加速其普及應用。在新興市場，醫療基礎設施的改善可望創造巨大的成長機會。此外，持續推動擴大急救醫療設備普及範圍的努力也將推動市場擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球去心房顫動市場：依產品分類

• 市場分析、洞察與預測
• 植入式心臟整流去顫器
• 體外去心房顫動

第5章 全球去心房顫動市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診所和心臟中心
• 院外醫療環境
• 公共准入市場
• 居家醫療環境
• 替代醫學機構

第6章 全球去心房顫動市場：依患者類型分類

• 市場分析、洞察與預測
• 成人
• 兒童

第7章 全球去心房顫動市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • Stryker
  • Nihon Koken Kogyo Co. Ltd
  • Zoll Medical Corporation
  • Biotronik Se & Co Kg
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • Physio-Control Inc
  • LivaNova PLC
  • Asahi Kasei Corporation
  • Schiller
  • Mediana Co. Ltd
  • Meltrax GmbH
  • Abbott

The Defibrillators Market size is expected to reach USD 34.71 Billion in 2034 from USD 18.99 Billion (2025) growing at a CAGR of 6.93% during 2026-2034.

The global defibrillators market is experiencing strong growth due to the rising incidence of cardiovascular diseases and sudden cardiac arrest cases. Defibrillators are life-saving devices that deliver electric shocks to restore normal heart rhythm. The increasing awareness about emergency medical care and the growing availability of automated external defibrillators (AEDs) in public places are key factors driving market expansion. Additionally, advancements in medical technology are improving device efficiency and usability.

Key growth drivers include the increasing adoption of portable and user-friendly defibrillators in hospitals, ambulances, and public spaces. Government initiatives promoting the installation of AEDs in public areas are also contributing to market growth. The growing focus on improving emergency response systems and increasing training programs for CPR and defibrillator use are further supporting demand. Furthermore, technological advancements are enhancing device reliability and performance.

Looking ahead, the defibrillators market is expected to grow significantly with continuous innovation and increasing awareness about cardiac health. The development of connected and smart defibrillators with real-time monitoring capabilities will further enhance adoption. Emerging markets are anticipated to provide substantial growth opportunities due to improving healthcare infrastructure. Additionally, ongoing efforts to expand access to emergency medical equipment will drive market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Implantable Cardioverter Defibrillators
• External Defibrillators

By End User

• Hospitals
• Clinics and Cardiac Centres
• Pre-Hospital Care Settings
• Public Access Markets
• Home Care Settings
• Alternate Care Facilities

By Patient Type

• Adult
• Pediatric

COMPANIES PROFILED

• Medtronic, Boston Scientific Corporation, Koninklijke Philips NV, Stryker, Nihon Koken Kogyo Co Ltd, Zoll Medical Corporation, Biotronik Se Co Kg, Shenzhen Mindray Bio Medical Electronics Co Ltd, PhysioControl Inc, LivaNova PLC, Asahi Kasei Corporation, Schiller, Mediana Co Ltd, Metrax GmbH, Abbott
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DEFIBRILLATORS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Implantable Cardioverter Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. External Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DEFIBRILLATORS MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics and Cardiac Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Pre-Hospital Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Public Access Markets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Alternate Care Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DEFIBRILLATORS MARKET: BY PATIENT TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Patient Type
• 6.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DEFIBRILLATORS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By End User
  • 7.2.3 By Patient Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By End User
  • 7.3.3 By Patient Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By End User
  • 7.4.3 By Patient Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By End User
  • 7.5.3 By Patient Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By End User
  • 7.6.3 By Patient Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DEFIBRILLATORS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Koninklijke Philips N.V
  • 9.2.4 Stryker
  • 9.2.5 Nihon Koken Kogyo Co. Ltd
  • 9.2.6 Zoll Medical Corporation
  • 9.2.7 Biotronik Se & Co Kg
  • 9.2.8 Shenzhen Mindray Bio- Medical Electronics Co. Ltd
  • 9.2.9 Physio-Control Inc
  • 9.2.10 LivaNova PLC
  • 9.2.11 Asahi Kasei Corporation
  • 9.2.12 Schiller
  • 9.2.13 Mediana Co. Ltd
  • 9.2.14 Meltrax GmbH
  • 9.2.15 Abbott